masitinib

Ligand id: 5656

Name: masitinib

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 7
Hydrogen bond donors 2
Rotatable bonds 8
Topological polar surface area 101.63
Molecular weight 498.22
XLogP 4.52
No. Lipinski's rules broken 0

Molecular properties generated using the CDK

Classification
Compound class Synthetic organic
IUPAC Name
N-(4-methyl-3-{[4-(pyridin-3-yl)-1,3-thiazol-2-yl]amino}phenyl)-4-[(4-methylpiperazin-1-yl)methyl]benzamide
International Nonproprietary Names
INN number INN
8779 masitinib
Synonyms
AB-1010 | AB1010 | Masican® (proposed trade name)
Database Links
CAS Registry No. 790299-79-5
ChEMBL Ligand CHEMBL1908391
PubChem CID 10074640
Search Google for chemical match using the InChIKey WJEOLQLKVOPQFV-UHFFFAOYSA-N
Search Google for chemicals with the same backbone WJEOLQLKVOPQFV
Search PubMed clinical trials masitinib
Search PubMed titles masitinib
Search PubMed titles/abstracts masitinib
Search UniChem for chemical match using the InChIKey WJEOLQLKVOPQFV-UHFFFAOYSA-N
Search UniChem for chemicals with the same backbone WJEOLQLKVOPQFV
Wikipedia Masitinib
Comments
Using the trade name Masivet, this compound has been used for several years to treat mast cell tumours in dogs [5]. It is a receptor tyrosine kinase (RTK) inhibitor, with inhibitory activity at the cKIT, platelet derived growth factor receptor (PDGFR) and fibroblast growth factor receptor (FGFR) RTKs [3].